VBI Vaccines (VBI Vaccines) Price-to-Tangible-Book : (As of May. 18, 2024)

View and export this data going back to . Start your Free Trial

What is VBI Vaccines Price-to-Tangible-Book?

As of today (2024-05-18), VBI Vaccines's share price is $4.61. VBI Vaccines's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.00. Hence, VBI Vaccines's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for VBI Vaccines's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, VBI Vaccines's highest Price to Tangible Book Ratio was 27.35. The lowest was 0.27. And the median was 6.33.

SVACD's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.85
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, VBI Vaccines's share price is $4.61. VBI Vaccines's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.00. Hence, VBI Vaccines's P/B Ratio of today is .

VBI Vaccines Price-to-Tangible-Book Historical Data

The historical data trend for VBI Vaccines's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VBI Vaccines Price-to-Tangible-Book Chart

VBI Vaccines Annual Data

Trend

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

VBI Vaccines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of VBI Vaccines's Price-to-Tangible-Book

For the Biotechnology subindustry, VBI Vaccines's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VBI Vaccines's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VBI Vaccines's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where VBI Vaccines's Price-to-Tangible-Book falls into.

VBI Vaccines Price-to-Tangible-Book Calculation

VBI Vaccines's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	4.61	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

VBI Vaccines Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

VBI Vaccines (VBI Vaccines) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (OTCPK:SVACD) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

VBIV:USA LO9A:Germany

Address

160 Second Street, Floor 3, Cambridge, MA, USA, 02142

Website

https://www.vbivaccines.com

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.